Evidence map›Paper›PMID 36581367›Full record

ArticleInternational journal of stem cells2023

Inhibition of Class I Histone Deacetylase Enhances Self-Reprogramming of Spermatogonial Stem Cells into Pluripotent Stem Cells.

Yukyeong Lee, Seung-Won Lee, Dahee Jeong, Hye Jeong Lee, Na Young Choi, Jin Seok Bang, Seokbeom Ham, Kinarm Ko

Open access · diamondAbstract read
In one paragraph

Article in International journal of stem cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yukyeong LeeDepartment of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea.
Seung-Won LeeDepartment of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea.
Dahee JeongDepartment of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea.
Hye Jeong LeeDepartment of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea.
Na Young ChoiDepartment of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea.
Jin Seok BangDepartment of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea.
Seokbeom HamDepartment of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea.
Kinarm KoDepartment of Stem Cell Biology, Konkuk University School of Medicine, Seoul, Korea.
Konkuk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Spermatogonial stem cells (SSCs) are the most primitive cells in spermatogenesis and are the only adult stem cells capable of passing on the genome of a given species to the next generation. SSCs are the only adult stem cells known to exhibit high Oct4 expression and can be induced to self-reprogram into pluripotent cells depending on culture conditions. Epigenetic modulation is well known to be involved in the induction of pluripotency of somatic cells. However, epigenetic modulation in self-reprogramming of SSCs into pluripotent cells has not been studied. Methods and Results: In this study, we examined the involvement of epigenetic modulation by assessing whether self-reprogramming of SSCs is enhanced by treatment with epigenetic modulators. We found that second-generation selective class I HDAC inhibitors increased SSC reprogramming efficiency, whereas non-selective HDAC inhibitors had no effect. Conclusions: We showed that pluripotent stem cells derived from adult SSCs by treatment with small molecules with epigenetic modulator functions exhibit pluripotency

Indexed as

Epigenetic modulatorEpigenetic reprogrammingHDAC inhibitorSelf-reprogrammingSpermatogonial stem cellsSSCs

Identifiers

PMID36581367
PMCPMC9978831
OpenAlexW4313311875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.